: Fragile X syndrome (FXS) is the most common form of monogenic intellectual disability and autism, caused by the absence of the functional fragile X messenger ribonucleoprotein 1 (FMRP). FXS features include increased and dysregulated protein synthesis, observed in both murine and human cells. Altered processing of the amyloid precursor protein (APP), consisting of an excess of soluble APPα (sAPPα), may contribute to this molecular phenotype in mice and human fibroblasts. Here we show an age-dependent dysregulation of APP processing in fibroblasts from FXS individuals, human neural precursor cells derived from induced pluripotent stem cells (iPSCs), and forebrain organoids. Moreover, FXS fibroblasts treated with a cell-permeable peptide that decreases the generation of sAPPα show restored levels of protein synthesis. Our findings suggest the possibility of using cell-based permeable peptides as a future therapeutic approach for FXS during a defined developmental window.

Cencelli, G., Pacini, L., De Luca, A., Messia, I., Gentile, A., Kang, Y., et al. (2023). Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals. CELLS, 12(5) [10.3390/cells12050758].

Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals

De Luca, Anastasia;Gentile, Antonietta;Farace, Maria Giulia;Bagni, Claudia
2023-02-27

Abstract

: Fragile X syndrome (FXS) is the most common form of monogenic intellectual disability and autism, caused by the absence of the functional fragile X messenger ribonucleoprotein 1 (FMRP). FXS features include increased and dysregulated protein synthesis, observed in both murine and human cells. Altered processing of the amyloid precursor protein (APP), consisting of an excess of soluble APPα (sAPPα), may contribute to this molecular phenotype in mice and human fibroblasts. Here we show an age-dependent dysregulation of APP processing in fibroblasts from FXS individuals, human neural precursor cells derived from induced pluripotent stem cells (iPSCs), and forebrain organoids. Moreover, FXS fibroblasts treated with a cell-permeable peptide that decreases the generation of sAPPα show restored levels of protein synthesis. Our findings suggest the possibility of using cell-based permeable peptides as a future therapeutic approach for FXS during a defined developmental window.
27-feb-2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/13 - BIOLOGIA APPLICATA
English
ADAM10
APP processing
Fragile X syndrome
SAP97
iPSCs
peptide therapy
protein synthesis
Cencelli, G., Pacini, L., De Luca, A., Messia, I., Gentile, A., Kang, Y., et al. (2023). Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals. CELLS, 12(5) [10.3390/cells12050758].
Cencelli, G; Pacini, L; De Luca, A; Messia, I; Gentile, A; Kang, Y; Nobile, V; Tabolacci, E; Jin, P; Farace, Mg; Bagni, C
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/321130
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact